Summary
68.01 0.50(0.73%)07/05/2024
Conmed Corp. (CNMD)
Conmed Corp. (CNMD)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 0.73 | -0.03 | -12.63 | -13.55 | -37.77 | -49.64 | -19.32 | 3,340.31 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 68.01 | |
| Open | 67.65 | |
| High | 68.05 | |
| Low | 66.94 | |
| Volume | 63,128 | |
| Change | 0.50 | |
| Change % | 0.73 | |
| Avg Volume (20 Days) | 372,224 | |
| Volume/Avg Volume (20 Days) Ratio | 0.17 | |
| 52 Week Range | 61.05 - 137.86 | |
| Price vs 52 Week High | -50.67% | |
| Price vs 52 Week Low | 11.39% | |
| Range | -0.10 | |
| Gap Up/Down | -0.13 | |
Fundamentals | ||
| Market Capitalization (Mln) | 2,079 | |
| EBIDTA | 206,548,000 | |
| PE Ratio | 27.2644 | |
| PEG Ratio | 5.2900 | |
| WallStreet Target Price | 94.86 | |
| Book Value | 27.7570 | |
| Earnings Per Share | 2.6100 | |
| EPS Estimate Current Quarter | 0.7400 | |
| EPS Estimate Next Quarter | 0.9700 | |
| EPS Estimate Current Year | 4.2900 | |
| EPS Estimate Next Year | 5.5000 | |
| Diluted EPS (TTM) | 2.6100 | |
| Revenues | ||
| Profit Marging | 0.0653 | |
| Operating Marging (TTM) | 0.0963 | |
| Return on asset (TTM) | 0.0368 | |
| Return on equity (TTM) | 0.1025 | |
| Revenue TTM | 1,261,549,056 | |
| Revenue per share TTM | 41.0460 | |
| Quarterly Revenue Growth (YOY) | 0.0570 | |
| Quarterly Earnings Growth (YOY) | 9.5670 | |
| Gross Profit (TTM) | 575,745,000 | |
| Dividends | ||
| Dividend Share | 0.8000 | |
| Dividend Yield | 0.0112 | |
| Valuations | ||
| Trailing PE | 27.2644 | |
| Forward PE | 27.0270 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 2.7528 | |
| Revenue Enterprise Value | 2.6077 | |
| EBITDA Enterprise Value | 16.8641 | |
| Shares | ||
| Shares Outstanding | 30,800,700 | |
| Shares Float | 30,529,392 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.16 | |
| Insider (%) | 0.55 | |
| Institutions (%) | 120.75 | |
06/27 10:45 EST - zacks.com
Here's Why You Should Retain CONMED (CNMD) Stock for Now
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
Here's Why You Should Retain CONMED (CNMD) Stock for Now
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
05/23 16:05 EST - businesswire.com
CONMED Corporation to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference at 8:00 a.m. ET on Thursday, June 6, 2024. A live webcast of the fireside chat will be accessible through the “Investors” section of the Company's website at www.conmed.com and will b.
CONMED Corporation to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference at 8:00 a.m. ET on Thursday, June 6, 2024. A live webcast of the fireside chat will be accessible through the “Investors” section of the Company's website at www.conmed.com and will b.
05/22 16:05 EST - businesswire.com
CONMED Corporation Announces Quarterly Cash Dividend
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 22, 2024, payable on July 5, 2024, to all shareholders of record as of June 14, 2024. About CONMED Corporation CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orth.
CONMED Corporation Announces Quarterly Cash Dividend
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 22, 2024, payable on July 5, 2024, to all shareholders of record as of June 14, 2024. About CONMED Corporation CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orth.
05/19 14:08 EST - investorplace.com
Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains
Following the so-called “smart money” is often a wise strategy for retail investors. Most individual investors fail to outperform the broader market over the long-run.
Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains
Following the so-called “smart money” is often a wise strategy for retail investors. Most individual investors fail to outperform the broader market over the long-run.
05/01 16:05 EST - businesswire.com
CONMED Corporation to Present at the BofA Securities Healthcare Conference
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat Beyer, Chief Operating Officer, will present at the BofA Securities Healthcare Conference at 2:20 p.m. PT (5:20 p.m. ET) on Tuesday, May 14, 2024 in Las Vegas, NV. A live audio webcast of the presentation will be accessible through the “Investors” section of th.
CONMED Corporation to Present at the BofA Securities Healthcare Conference
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat Beyer, Chief Operating Officer, will present at the BofA Securities Healthcare Conference at 2:20 p.m. PT (5:20 p.m. ET) on Tuesday, May 14, 2024 in Las Vegas, NV. A live audio webcast of the presentation will be accessible through the “Investors” section of th.
04/25 13:45 EST - zacks.com
CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates
CONMED's (CNMD) adjusted first-quarter earnings and revenues beat estimates on the back of strong U.S. and International markets as well as supply-chain improvement.
CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates
CONMED's (CNMD) adjusted first-quarter earnings and revenues beat estimates on the back of strong U.S. and International markets as well as supply-chain improvement.
04/25 01:16 EST - seekingalpha.com
CONMED Corporation (CNMD) Q1 2024 Earnings Call Transcript
Call End: CONMED Corporation (NYSE:CNMD ) Q1 2024 Earnings Conference Call April 24, 2024, 16:30 PM ET Company Participants Curt Hartman - Chair, President and Chief Executive Officer Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Matt O'Brien - Piper Sandler Young Li - Jefferies Vik Chopra - Wells Fargo Kristen Stewart - CL King Rick Wise - Stifel Robbie Marcus - J.P. Morgan Travis Steed - BofA Securities Mike Matson - Needham Operator Thank you for standing by and welcome to CONMED's First Quarter Fiscal Year 2024 Earnings Conference Call.
CONMED Corporation (CNMD) Q1 2024 Earnings Call Transcript
Call End: CONMED Corporation (NYSE:CNMD ) Q1 2024 Earnings Conference Call April 24, 2024, 16:30 PM ET Company Participants Curt Hartman - Chair, President and Chief Executive Officer Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Matt O'Brien - Piper Sandler Young Li - Jefferies Vik Chopra - Wells Fargo Kristen Stewart - CL King Rick Wise - Stifel Robbie Marcus - J.P. Morgan Travis Steed - BofA Securities Mike Matson - Needham Operator Thank you for standing by and welcome to CONMED's First Quarter Fiscal Year 2024 Earnings Conference Call.
04/24 20:01 EST - zacks.com
Conmed (CNMD) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Conmed (CNMD) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
04/24 18:16 EST - zacks.com
Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates
Conmed (CNMD) came out with quarterly earnings of $0.79 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.66 per share a year ago.
Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates
Conmed (CNMD) came out with quarterly earnings of $0.79 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.66 per share a year ago.
04/24 16:05 EST - businesswire.com
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Patrick Beyer, President of International and Global Orthopedics, has been promoted to the newly created role of Chief Operating Officer (COO), effective immediately. In this role, Mr. Beyer will take on additional responsibility for leading the Company's commercial businesses, as well as Operations, Distribution, Regulatory Affairs / Quality Assurance, and Customer Excellence. “Pat has been invaluable in driving.
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Patrick Beyer, President of International and Global Orthopedics, has been promoted to the newly created role of Chief Operating Officer (COO), effective immediately. In this role, Mr. Beyer will take on additional responsibility for leading the Company's commercial businesses, as well as Operations, Distribution, Regulatory Affairs / Quality Assurance, and Customer Excellence. “Pat has been invaluable in driving.
04/24 16:03 EST - businesswire.com
CONMED Corporation Announces First Quarter 2024 Financial Results
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Sales of $312.3 million increased 5.7% year-over-year as reported and 5.9% in constant currency. Domestic revenue increased 7.2% year-over-year. International revenue increased 3.8% year-over-year as reported and 4.2% in constant currency. Diluted net earnings per share (GAAP) were $0.63 compared to diluted net earnings per sha.
CONMED Corporation Announces First Quarter 2024 Financial Results
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Sales of $312.3 million increased 5.7% year-over-year as reported and 5.9% in constant currency. Domestic revenue increased 7.2% year-over-year. International revenue increased 3.8% year-over-year as reported and 4.2% in constant currency. Diluted net earnings per share (GAAP) were $0.63 compared to diluted net earnings per sha.
04/02 16:05 EST - businesswire.com
CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2024 after the market close on Wednesday, April 24, 2024. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed fro.
CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2024 after the market close on Wednesday, April 24, 2024. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed fro.
03/25 18:00 EST - investorplace.com
3 Retirement Stocks to Buy at a 52-Week Low in March
Despite significant challenges, the U.S. economy has showcased remarkable resilience. Fears of an imminent recession have been allayed by two consecutive quarters of robust GDP growth exceeding 3%.
3 Retirement Stocks to Buy at a 52-Week Low in March
Despite significant challenges, the U.S. economy has showcased remarkable resilience. Fears of an imminent recession have been allayed by two consecutive quarters of robust GDP growth exceeding 3%.
02/02 11:11 EST - zacks.com
CONMED (CNMD) Misses on Q4 Earnings, Beats Revenue Estimates
CONMED's (CNMD) adjusted fourth-quarter earnings misses while sales beat estimates on the back of strong growth in the United States and international markets. Gross margin improves with a rise in sales.
CONMED (CNMD) Misses on Q4 Earnings, Beats Revenue Estimates
CONMED's (CNMD) adjusted fourth-quarter earnings misses while sales beat estimates on the back of strong growth in the United States and international markets. Gross margin improves with a rise in sales.
01/31 21:17 EST - seekingalpha.com
CONMED Corporation (CNMD) Q4 2023 Earnings Call Transcript
CONMED Corporation (CNMD) Q4 2023 Earnings Call Transcript
CONMED Corporation (CNMD) Q4 2023 Earnings Call Transcript
CONMED Corporation (CNMD) Q4 2023 Earnings Call Transcript
01/31 19:01 EST - zacks.com
Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings
While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings
While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
01/31 18:21 EST - zacks.com
Conmed (CNMD) Lags Q4 Earnings and Revenue Estimates
Conmed (CNMD) came out with quarterly earnings of $1.06 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.42 per share a year ago.
Conmed (CNMD) Lags Q4 Earnings and Revenue Estimates
Conmed (CNMD) came out with quarterly earnings of $1.06 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.42 per share a year ago.
01/31 16:05 EST - businesswire.com
CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2023. Fourth Quarter 2023 Highlights Sales of $327.0 million increased 30.4% year over year as reported and 31.5% in constant currency Domestic revenue increased 33.3% year over year. International revenue increased 26.5% year over year as reported and 29.0% in constant currency. Diluted net earnings per share (GAAP) were $1.05 compared to dilut.
CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2023. Fourth Quarter 2023 Highlights Sales of $327.0 million increased 30.4% year over year as reported and 31.5% in constant currency Domestic revenue increased 33.3% year over year. International revenue increased 26.5% year over year as reported and 29.0% in constant currency. Diluted net earnings per share (GAAP) were $1.05 compared to dilut.